WHO Option B+: Early Experience of Antiretroviral Therapy Sequencing after Cessation of Breastfeeding and Risk of Dermatologic Toxicity.
*Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, CA †Makerere University-University of California San Francisco Research Collaboration ‡Department of Obstetrics and Gynecology, New York University, NY §Department of Medicine, Center for AIDS Prevention Studies, University of California San Francisco, CA ‖Department of Pediatrics, Makerere University, Kampala, Uganda ¶Department of Medicine, HIV/AIDS Division at San Francisco General Hospital, University of California San Francisco, CA #Department of Medicine, Makerere University, Kampala, Uganda.JAIDS Journal of Acquired Immune Deficiency Syndromes (Impact Factor: 4.56). 03/2013; 62(3):e101-e103. DOI: 10.1097/QAI.0b013e31828011ca
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.